Primed Medicine Omc S.R.L.
- Address
- lock Available on a paid plan
Primed Medicine OMC S.R.L. - HPV and Women's Health Research
Primed Medicine OMC S.R.L. is a clinical research center dedicated to advancing therapeutic solutions for viral infections affecting women's reproductive health. The center specializes in conducting rigorous clinical trials focused on high-risk oncogenic human papillomavirus (HR-HPV) infections, a critical area of gynecological health with significant implications for cervical cancer prevention.
- High-risk oncogenic HPV genital infection clearance
- Placebo-controlled therapeutic efficacy studies
- Women's reproductive health interventions
The research center employs sophisticated randomized, double-blind, placebo-controlled study designs to evaluate innovative therapeutic approaches for persistent HPV infections. With extended follow-up periods and focus on measurable clinical outcomes such as viral clearance, Primed Medicine OMC S.R.L. contributes valuable evidence to the development of treatments that may reduce the burden of HPV-related diseases and potentially prevent progression to cervical dysplasia and cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Labo'Life Belgium1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Primed Medicine Omc S.R.L.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of 2LPAPI on Clearance of Genital High-Risk Human Papillomavirus Infections: A Randomized, Double-Blind, Placebo-Controlled Trial | Labo'Life Belgium | Phase III | Recruiting | May 2024 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ciclosporin A | 1 | Unknown | 2024-05-09 | 2024-05-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.